May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

Can Herbs Be Used for the Treatment of Obesity-Linked Thyroiditis?

A new study found that five traditional herbs may influence obesity-linked Hashimoto’s thyroiditis through a process called efferocytosis, with quercetin emerging as a key compound involved in regulating immune activity.

Conexiant

May 19, 2025

Growth Disrupted in One-Third of JIA Patients, Study

In a study of 107 children with juvenile idiopathic arthritis, researchers found that one-third had growth or pubertal disturbances—often linked to disrupted hormone levels and longer disease duration.

Conexiant

May 16, 2025

Semaglutide Use Linked to Fewer Foot Ulcers

A large-scale study found semaglutide use was associated with reduced risks of amputation, chronic pain, and wound complications in patients with diabetes-related foot ulcers.

Conexiant

May 16, 2025

Upadacitinib Maintains UC Remission Through 96 Weeks

A 3-year study found that most patients with moderate to severe ulcerative colitis who responded to initial upadacitinib treatment stayed in remission through 96 weeks, with manageable side effects and consistent results across dosage groups.

Conexiant

May 14, 2025

Home Wash Leaves Scrubs Full of Superbugs

Home washing machines often fail to disinfect health care workers' uniforms, leaving antibiotic-resistant bacteria behind.

Conexiant

May 07, 2025

Foot Device Beats PT for Back Pain

A personalized foot-worn device reduced pain by 56% in individuals with chronic low back pain compared to traditional physical therapy.

Conexiant

May 07, 2025

Corticosteroid Use Linked to Weight, Waist Gains

In a study of over 80,000 adults, long-term corticosteroid use—including inhaled and topical forms—was associated with gradual weight gain and waist enlargement, especially in women and those with overweight or obesity.

Conexiant

May 07, 2025

COVID-19 Vaccination May Lower Fibromyalgia Risk, Study

A large matched-cohort study found that COVID-19 vaccination was linked to a reduced risk of developing fibromyalgia among survivors, particularly in men and those with depression or anxiety.

Conexiant